LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There? Joost BesselingJulian van CapelleveenG. Kees Hovingh Current Opinion 14 March 2013 Pages: 293 - 301
Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research Cristan FarmerAudrey ThurmPaul Grant Leading Article 16 March 2013 Pages: 303 - 314
Promising New Molecular Targeted Therapies in Head and Neck Cancer Kelly DorseyMark Agulnik Leading Article 26 February 2013 Pages: 315 - 325
Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management Joe M. ChehadeMargaret GladyszArshag D. Mooradian Therapy in Practice 12 March 2013 Pages: 327 - 339
Targeting Interleukin-6 in Rheumatoid Arthritis Md Yuzaiful Md YusofPaul Emery Review Article 01 March 2013 Pages: 341 - 356
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments Bin-Chi LiaoChia-Chi LinJames Chih-Hsin Yang Review Article 12 March 2013 Pages: 357 - 369
Brentuximab Vedotin: A Review of Its Use in Patients with Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma Following Previous Treatment Failure Karly P. Garnock-Jones Adis Drug Evaluation 14 March 2013 Pages: 371 - 381
Lixisenatide: First Global Approval Shelley ElkinsonGillian M. Keating R&D INSIGHT REPORT 05 April 2013 Pages: 383 - 391